69097084407 - Alfuzosin HCL 10 mg extended-release tablet
National Drug Code
What is a NDC Code?
NDC (National Drug Code) codes are unique identifiers for medications and pharmaceutical products in the United States. Each NDC code identifies the specific drug, its manufacturer, package size, and type, helping ensure accurate medication tracking and billing.
Detailed Description
This NDC code represents Alfuzosin hydrochloride 10 mg extended-release tablets taken by mouth. Alfuzosin is a medication commonly prescribed to treat symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH) in men. The extended-release formulation means the medication is designed to release slowly over 24 hours, typically requiring once-daily dosing. This medication is not approved for use in children.
Additional Information
This is an oral extended-release tablet formulation that should be taken as directed by a healthcare provider. The medication is specifically not indicated for use in children or pediatric patients.
Category
Prescription Medication
Medical Specialty
Urology
Expected Costs
Your actual cost will depend on your insurance coverage, provider location, and specific circumstances.
What's Required Before This
- Prescription required
- Adult male patients only
- Not indicated for pediatric use
What to Expect After
- Regular monitoring by prescribing physician
- Blood pressure monitoring may be needed
- Follow-up for symptom improvement
Why Understanding This Code Matters
On Your Medical Bill
This code appears on your medical bills to identify the specific service, procedure, drug, or medical diagnosis you received. Understanding what it means helps you verify you're being charged correctly and know what to expect.
For Your Health
Knowing what this code represents helps you understand your treatment plan, ask better questions during appointments, and track your healthcare journey more effectively.
Want This Level of Detail on All Your Claims?
Get detailed explanations for every medical code on your Medicare bills. Currently supporting Medicare only.